The Pennant Group, Inc. (PNTG) Q1 2026 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call highlights strong financial performance, optimistic guidance, and strategic growth initiatives. Positive factors include a 9.1% EPS increase, improved cash flows, and successful integration of acquisitions. The Q&A reveals confidence in operational efficiencies and growth prospects, despite some macroeconomic pressures. The company's focus on partnerships, expansions, and operational excellence further supports a positive outlook. However, management's lack of clarity on certain long-term macroeconomic impacts tempers the sentiment slightly. Overall, the company's strategic initiatives and financial improvements suggest a likely positive stock price movement.
Key Financial Performance
Revenue $285.4 million, up $75.5 million or 36% year-over-year. The increase is attributed to strong results across businesses and operational improvements.
Adjusted EBITDA $21.7 million, up $5.3 million or 32.6% year-over-year. Growth driven by operational improvements and momentum across segments.
Adjusted EBITDA prior to NCI $23.5 million, up $6.4 million or 37.2% year-over-year. Reflects operational improvements and strong performance in new and mature operations.
Adjusted diluted earnings per share $0.32, up $0.05 or 18.5% year-over-year. Growth attributed to operational improvements and strong segment performance.
Home Health and Hospice segment revenue $229.1 million, up $69.2 million or 43.3% year-over-year. Growth driven by consistent growth in existing operations and effective transitions in newer operations.
Home Health and Hospice segment adjusted EBITDA $33.6 million, up $8.5 million or 33.7% year-over-year. Reflects consistent growth and operational excellence.
Home Health admissions 30,721, an increase of 62.7% year-over-year. Medicare Home Health admissions rose to 13,303, an increase of 75.1%. Growth driven by strong clinical outcomes and operational improvements.
Same-store admission growth 5.8% year-over-year. Same-store Medicare admission growth was 9.2%. Growth attributed to operational excellence and leadership development.
Hospice average daily census 5,199, an increase of 37% year-over-year. Same-store Hospice average daily census grew to 3,952, an increase of 10.2%. Growth driven by clinical outcomes and payer relationships.
Senior Living segment revenue $56.3 million, up $6.3 million or 12.6% year-over-year. Growth attributed to operational improvements and leadership development.
Senior Living segment adjusted EBITDA $6.4 million, up $1.5 million or 30.6% year-over-year. Segment adjusted EBITDA margin improved to 11.8%, a 190 basis point increase. Growth driven by operational improvements and occupancy gains.
Same-store occupancy (Senior Living) 81%, up 180 basis points year-over-year. Growth attributed to operational improvements and leadership development.
All-store occupancy (Senior Living) 78.6%, up 10 basis points year-over-year. Sequential decline of 200 basis points due to acquisitions of low occupancy communities and holiday seasonality.
GAAP net income $8.5 million, up $0.7 million or 9.6% year-over-year. Growth attributed to operational improvements and segment performance.
Adjusted net income $11.5 million, up $1.9 million or 19.8% year-over-year. Growth attributed to operational improvements and segment performance.
GAAP diluted earnings per share $0.24, up $0.02 or 9.1% year-over-year. Growth attributed to operational improvements and segment performance.
Cash flows used in operations $3.4 million, an improvement of $17.8 million year-over-year. Improvement attributed to operational efficiencies.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Expansion in Southeast: Transitioned 54 Home Health, Hospice, and Home Care operations in Tennessee, Alabama, and Georgia. Integration is progressing as expected, with completion anticipated by the end of Q3 2026.
Senior Living Acquisitions: Acquired Lavender Lane Senior Living in Phoenix, Arizona, and three additional senior living communities in Arizona and Wisconsin, expanding presence in strategic markets.
Revenue Growth: Achieved revenue of $285.4 million, a 36% increase from the prior year.
Home Health and Hospice Segment Growth: Revenue increased by 43.3% to $229.1 million. Total Home Health admissions rose by 62.7%, and Medicare Home Health admissions increased by 75.1%.
Senior Living Segment Growth: Revenue grew by 12.6% to $56.3 million, with adjusted EBITDA increasing by 30.6%. Same-store occupancy rose to 81%.
Operational Efficiency: Improved same-store segment adjusted EBITDA margins and reduced expenses through integration efforts.
Leadership Development: Added 47 CEOs-in-training in 2026 and elevated 55 CEOs and 92 other C-level leaders to drive operational results.
Focus on Integration: Prioritized integration of new acquisitions and operations to unlock value and improve margins.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Leadership Recruitment and Development: The company faces challenges in recruiting and developing exceptional leaders to sustain its growth trajectory, especially after the large acquisitions in 2025. This is critical for maintaining operational performance and achieving strategic objectives.
Operational Integration: The transition of operations in Tennessee, Alabama, and Georgia from UnitedHealthcare presents challenges, including maintaining census during EMR transitions, seasonal admission trends, and severe weather disruptions. These factors could impact operational performance and financial outcomes.
Labor Costs and Wage Pressure: Continued wage pressure in the labor market poses a challenge to maintaining profitability, particularly in the Home Health and Hospice segment.
Regulatory Risks: The company is subject to regulatory changes, such as the proposed 2026 hospice rule, which could impact reimbursement rates and financial performance.
Occupancy Volatility in Senior Living: The company faces challenges in stabilizing occupancy rates in its Senior Living segment, particularly with newly acquired underperforming communities. This could lead to short-term financial volatility.
Debt Levels and Cash Flow: The company has $170.8 million in outstanding debt under its credit facility and reported cash flows used in operations of $3.4 million, which could pose financial risks if not managed effectively.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Operational Performance Improvement: The company is committed to improving operational performance in both new and mature operations throughout 2026. Same-store segment adjusted EBITDA margins are on an upward trajectory, with expectations to unlock meaningful value in operations.
Leadership Development: The company has added 47 CEOs-in-training in 2026 year-to-date and elevated 55 CEOs and 92 other C-level leaders to drive results. This robust leadership pipeline positions the company for future growth.
Southeast Operations Transition: The transition of operations in Tennessee, Alabama, and Georgia is progressing as planned, with full integration expected by October 2026. Improved operational performance and cost reductions are anticipated as the transition progresses.
Home Health and Hospice Segment Growth: The company expects continued growth in the Home Health and Hospice segment, with a target of achieving an 18% segment adjusted EBITDA margin as new operations are fully integrated. The 2026 hospice rule, including a 2.4% rate increase, is expected to provide a tailwind in Q4 2026.
Senior Living Segment Expansion: The company plans to remain active in acquiring Senior Living communities throughout 2026, supported by strong operational performance and leadership development. Recent acquisitions in Arizona and Wisconsin are expected to contribute to growth.
Pipeline and Acquisitions: The company is evaluating a pipeline of Home Health and Hospice tuck-ins and potential joint ventures, with plans to pursue opportunities that meet disciplined criteria without distracting from integration efforts.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Can you speak to the integration progress with the Amedisys-United assets and its impact on margins for the remainder of the year?
A:The integration is progressing well, with the first two waves completed and the third wave underway. The third and fourth waves are the largest. Leadership development is ongoing, with some leaders completing training and stepping into roles. KPIs show a rebound in census post-EMR transition, despite challenges like winter storms. Margins are on target, with transition costs expected to roll off as systems improve clinical outcomes.
Q:How should we think about CapEx trends over the course of the year?
A:CapEx spend will be heavier in the first part of the year due to acquisitions in Q4 for the Senior Living side. Total CapEx for the year is expected to be $15 million to $18 million.
Q:What is the receptivity of hospitals to signing JVs with you on the Home Health side?
A:Hospitals are receptive due to the company's track record of improving underperforming parts of their business, reducing mortality and readmission rates, and improving chronic care. The company is selective in partnerships, focusing on those with a commitment to clinical excellence and financial performance.
Q:What are the same-store trends in Home Health, particularly Medicare admission growth?
A:Medicare admission growth is strong, driven by being chosen as the provider of choice in communities. The company is monitoring macroeconomic factors and market share execution, with optimism about continued growth.
Q:What are the same-store growth trends in hospice, and are there any macroeconomic pressures like fuel costs?
A:Same-store hospice ADC improved by 10.2%, driven by better relationships and execution. Cap management is improving, particularly in high-reimbursement areas like California. Fuel costs are being monitored, with potential adjustments like stipends or mileage rate increases if prices remain elevated.
Q:What are the opportunities in the Southeast expansion and the impact of increased focus on waste, fraud, and abuse?
A:The Southeast expansion has led to broader payer conversations and better contracts. The focus on waste, fraud, and abuse is seen as an opportunity to differentiate and gain market share, especially in areas where bad actors are removed.
Q:What is the timing of the integration process for the remaining waves?
A:The third and fourth waves, the largest, are underway and expected to be completed by early Q3. TSA expenses will drop significantly as the integration winds down.
Q:Are there markets where competition for short-stay hospice admissions could be a headwind for cap management?
A:Yes, particularly in high-reimbursement markets like California. Local teams are using various tactics to manage cap pressures, including outreach to the community and focusing on patient appropriateness.
Q:What is the status of newer Senior Living acquisitions, and what is the expected performance improvement?
A:The newer acquisitions are distressed assets with significant upside. The company is improving these assets through integration and operational enhancements, with examples like Capitol Hill Senior Living showing substantial improvement over time.
Q:What is driving the guidance push towards the upper end, and is it related to Q1 performance?
A:The guidance push is partly due to strong Q1 performance, including same-store improvements. However, the company is cautious and wants to see another quarter of results before making further adjustments.
Q:What is driving same-store margin improvements despite pressures like labor costs?
A:Same-store margin improvements are driven by better care planning, reduced visits per episode, strong home health value-based purchasing performance, and growth in hospice census.
Q:What is driving the increase in Medicaid mix in Senior Living, and what are the thoughts on Medicaid waivers?
A:The increase in Medicaid mix is due to local operators connecting with government agencies and serving vulnerable populations. Medicaid waivers are seen as durable and beneficial, with appropriate reimbursement levels and opportunities for growth in states like Wisconsin and Arizona.
Q:Review of Unclear Management Responses
A:Management avoided providing specific details on how macroeconomic factors like enrollment shift dynamics in Medicare or fuel costs might evolve in the long term. Additionally, they did not provide clarity on the exact financial impact of the Southeast expansion or the fraud, waste, and abuse focus on market share gains.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Alabama Georgia
CEOs level
Capitol Hill
Chief
Form
Health Home
Health admission
Home Care
Lane Senior
Living living
Medicare Home
Oregon
Riverside
Tennessee Alabama
admission increase
census increase
challenge
development
focus excellence
holiday seasonality
income increase
increase income
leader culture
leader focus
level leader
margin NCI
month
occupancy basis
reduction
result transition
segment margin
segment trajectory
share increase
store occupancy
system model
transition Home
PNTG Transcript
The Pennant Group, Inc. (PNTG) Q1 2026 Earnings Call Transcript
Positive5-7
The earnings call highlights strong financial performance, optimistic guidance, and strategic growth initiatives. Positive factors include a 9.1% EPS increase, improved cash flows, and successful integration of acquisitions. The Q&A reveals confidence in operational efficiencies and growth prospects, despite some macroeconomic pressures. The company's focus on partnerships, expansions, and operational excellence further supports a positive outlook. However, management's lack of clarity on certain long-term macroeconomic impacts tempers the sentiment slightly. Overall, the company's strategic initiatives and financial improvements suggest a likely positive stock price movement.
The Pennant Group, Inc. (PNTG) Q4 2025 Earnings Call Transcript
Positive2-26
The earnings call summary reveals strong growth across various segments, including Medicare admissions, hospice ADC, and senior living revenue. The company shows robust cash flow and strategic positioning in the Southeast market. The Q&A section indicates conservative guidance for integration but highlights positive joint venture performance and strategic opportunities. Despite some management ambiguity, the overall sentiment is positive, driven by strong financial performance and optimistic guidance.
The Pennant Group, Inc. (PNTG) Q3 2025 Earnings Call Transcript
Positive11-6
The earnings call indicates strong financial performance and growth across multiple segments. The positive sentiment is bolstered by optimistic guidance, significant revenue and EPS growth, and promising acquisition strategies. The Q&A reveals proactive management addressing challenges and opportunities, with employees and analysts showing optimism. Despite some uncertainties, the overall outlook remains positive, especially with the anticipated contributions from the Amedisys transaction and ongoing operational improvements.
The Pennant Group, Inc. (PNTG) Q2 2025 Earnings Call Transcript
Positive8-8
The earnings call summary indicates strong revenue growth across multiple segments, particularly in Home Health and Hospice. The Q&A section reveals a positive sentiment towards market opportunities and operational strategies, despite some uncertainties regarding regulatory impacts. The company has raised its revenue guidance, which is a positive indicator. The sentiment is further bolstered by strategic investments and anticipated margin improvements, suggesting a likely positive stock price movement over the next two weeks.
PNTG Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
